These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4802560

  • 1. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z, Moorhead JF, Tatler GL, Baillod RA, Wills MR.
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract] [Full Text] [Related]

  • 2. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A, McChesney R, Irvine RO, Dixon SR.
    N Z Med J; 1974 Dec 25; 80(530):540-4. PubMed ID: 4615274
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of biochemical with radiological findings in renal osteodystrophy.
    Moorhead JF, Varghese Z, Tatler GL, Baillod RA, Wills MR.
    Ann Clin Biochem; 1975 May 25; 12(3):126-31. PubMed ID: 15637920
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid suppressibility in renal osteodystrophy.
    Moorhead JF, Varghese Z, Tatler GL, Baillod RA, Ku G, Sweatman AJ, Wills MR.
    Proc Eur Dial Transplant Assoc; 1975 May 25; 11():465-72. PubMed ID: 1197271
    [No Abstract] [Full Text] [Related]

  • 5. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
    Ionova D, Zlatarska S, Kirjakov Z.
    Nephrol Dial Transplant; 1995 May 25; 10(9):1782. PubMed ID: 8559512
    [No Abstract] [Full Text] [Related]

  • 6. Thermolability of alkaline phosphatase in the evaluation of renal osteodystrophy.
    Sagar S, Borra S, Kaye M.
    Nephron; 1971 May 25; 8(3):270-7. PubMed ID: 5155279
    [No Abstract] [Full Text] [Related]

  • 7. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U.
    Minerva Med; 1985 Mar 10; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract] [Full Text] [Related]

  • 8. A possible role for propranolol in the treatment of renal osteodystrophy.
    Caro JF, Besarab A, Burke JF, Glennon JA.
    Lancet; 1978 Aug 26; 2(8087):451-4. PubMed ID: 79809
    [Abstract] [Full Text] [Related]

  • 9. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG, Ledingham JG, Norman AW, Oliver DO, Preston C, Russell RG, Small DG, Smith R, Warner GT, Woods CG.
    Proc Eur Dial Transplant Assoc; 1973 Aug 26; 10(0):202-9. PubMed ID: 4802654
    [No Abstract] [Full Text] [Related]

  • 10. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
    Labos I, Kovacević M.
    Med Arh; 1988 Aug 26; 42(4):181-5. PubMed ID: 3270761
    [No Abstract] [Full Text] [Related]

  • 11. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
    Wills MR, Fairney A, Varghese Z, Tatler GL, Baillod RA, Moorhead JF.
    Clin Chim Acta; 1974 Nov 20; 57(1):83-9. PubMed ID: 4430145
    [No Abstract] [Full Text] [Related]

  • 12. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency.
    Duursma SA, Visser WJ, Mees EJ, Njio L.
    Calcif Tissue Res; 1974 Nov 20; 16(2):129-38. PubMed ID: 4447892
    [No Abstract] [Full Text] [Related]

  • 13. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL, Brownjohn AM, Goodwin FJ, Hately W, Manning RM, O'Riordan JH, Papapoulos SE, Marsh FP.
    Q J Med; 1982 Nov 20; 51(203):271-8. PubMed ID: 7146311
    [Abstract] [Full Text] [Related]

  • 14. Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy.
    Uehara H.
    Nihon Jinzo Gakkai Shi; 1993 Jan 20; 35(1):49-58. PubMed ID: 8336400
    [Abstract] [Full Text] [Related]

  • 15. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G, Schaefer K, Schulz A, Delling G.
    Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299
    [Abstract] [Full Text] [Related]

  • 16. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY, Varghese Z, Meinhard EA, Baillod RA, Skinner RK, Wills MR, Moorhead JF.
    Adv Exp Med Biol; 1977 Jul 01; 81():581-90. PubMed ID: 899942
    [No Abstract] [Full Text] [Related]

  • 17. Linear decline in serum alkaline phosphatase activity during treatment of renal osteodystrophy.
    Will EJ, Knapp MS, McGivern D.
    Br Med J (Clin Res Ed); 1983 Jan 08; 286(6359):103. PubMed ID: 6401474
    [No Abstract] [Full Text] [Related]

  • 18. Parathyroidectomy in children with chronic renal failure.
    Firor HV, Moore ES, Levitsky LL, Galvez M.
    J Pediatr Surg; 1972 Jan 08; 7(5):565-72. PubMed ID: 5083161
    [No Abstract] [Full Text] [Related]

  • 19. Role of pyrophosphate in renal osteodystrophy.
    David DS, Sakai S, Granda J, Cheigh JS, Riggio RR, Stenzel KH, Rubin AL.
    Trans Am Soc Artif Intern Organs; 1973 Jan 08; 19():440-5. PubMed ID: 4352991
    [No Abstract] [Full Text] [Related]

  • 20. [Renal osteodystrophy].
    Schober HC.
    Z Urol Nephrol; 1986 Oct 08; 79(10):595-602. PubMed ID: 3811647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.